Early study finds new lymphoma drug effective
Eighty percent of patients with a subset of lymphoma saw their cancers shrink after taking zanubrutinib in a clinical trial.
May 13, 2022 5:00 AM
Mary Clare Fischer
Intermediate Public Relations Representative
Fischer promotes innovations in clinical care and tells patient stories on behalf of the Rogel Cancer Center while also managing external communications for Michigan Medicine’s surgery and urology departments and the Transplant Center. Before joining the university, she spent six years as a journalist. She has a passion for elevating translational research, highlighting the human element of science, and using a lens of diversity, equity and inclusion to shape her storytelling.
Operating rooms are the climate change contributor no one’s talking about
Two surgeons-in-training suggest some sustainable solutions for their energy-intensive discipline.
April 28, 2022 5:00 AM
Artificial intelligence helps physicians better assess the effectiveness of bladder cancer treatment
After consulting with a machine learning tool, providers were able to more accurately determine whether patients had a complete response to chemotherapy.
April 22, 2022 5:00 AM
More than one surgery is common for hernia patients
Repaired hernias redeveloped more than 15% of the time in older Americans.
March 01, 2022 11:00 AM
Melanoma referral centers worldwide adopt systemic therapies, reduce lymph node removal surgeries
Providers quickly integrated systemic medications to treat high-risk melanoma into their care after clinical trial results showed their efficacy while simultaneously forgoing lymph node removal surgeries.
March 01, 2022 9:45 AM
Side effects of radiation therapy reduced when computer optimizes treatment, study finds
A multi-center study found that breast cancer patients experienced less pain and skin irritation when a more complex form of treatment planning was used for radiation.
November 11, 2021 11:59 AM
